Jim Julian

Image006 2

Jim Julian acknowledges that his career path, like the GPS, has done a lot of “re-calculating”. From a student in the School of Architecture at Waterloo, quitting and working as a computer programmer, then returning to Architecture, then switching to Mathematics at Waterloo, quitting again and working as a cost clerk, then quality-control analyst, then industrial engineer, returning to school to complete a Statistics degree at McMaster, to graduate Statistics at Waterloo, to working as a research statistician, then epidemiologic researcher in McMaster’s Occupational Health Program, to faculty member in the Department of Clinical Epidemiology and Biostatistics, to tenured Associate Professor in that department, to winning consecutive teaching awards and a lifetime teaching award, and finally to clinical trials, the Department of Oncology and OCOG, where he is the Associate Director…

Now, in the twilight of his career, Jim collaborates with medical researchers to design and conduct studies in treating patients with cancer and with thrombosis (blood clots). His greatest joy is mentoring young biostatisticians.

Key Publications:

Moulton CA, Gu CS, Law CH, Tandan VR, Hart R, Quan D, Fairfull Smith RJ, Jalink DW, Husien M, Serrano PE, Hendler AL, Haider MA, Ruo L, Gulenchyn KY, Finch T, Julian JA, Levine MN, Gallinger S. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA. 2014 May 14;311(18):1863-9.

Schulman S, Parpia S, Stewart C, Rudd-Scott L, Julian JA, Levine M. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med. 2011 Nov 15;155(10):653-9.

Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010 Feb 11;362(6):513-20.